Remedent

Remedent Current Liabilities

The Current Liabilities of Remedent (REMI) as of Oct 9, 2026 is 2.88 M USD. In the previous year, Current Liabilities was 2.69 M USD — a change of 7.25% (higher).

Current Liabilities

2.88 MUSD

YoY

7.25%

Last updated:

Current Liabilities of Remedent is 2024 2.88 M USD. Current Liabilities of Remedent was 2023 2.69 M USD. It decreases by 7.25% higher compared to the previous year.

The Remedent Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2017
2.13 M USD
Jan 1, 2018
2.75 M USD
Jan 1, 2019
3.15 M USD
Jan 1, 2020
3.53 M USD
Jan 1, 2021
3.00 M USD
Jan 1, 2022
4.19 M USD
Jan 1, 2023
2.69 M USD
Jan 1, 2024
2.88 M USD
The Remedent Current Liabilities history
YEARCurrent LiabilitiesYoY
2.88 MUSD+7.25%
2.69 MUSD-35.88%
4.19 MUSD+39.44%
3.00 MUSD-14.87%
3.53 MUSD+12.11%
3.15 MUSD+14.40%
2.75 MUSD+29.39%
2.13 MUSD-66.61%
6.37 MUSD+0.66%
6.33 MUSD-9.00%
6.95 MUSD+11.57%
6.23 MUSD+14.49%
5.44 MUSD-29.42%
7.71 MUSD+65.13%
4.67 MUSD-16.83%
5.61 MUSD+18.08%
4.75 MUSD+7.49%
4.42 MUSD+11.72%
3.96 MUSD+79.64%
2.20 MUSD-26.30%
2.99 MUSD+35.41%
2.21 MUSD-99.87%
1.73 BUSD—
0.00USD—
0.00USD—
Access this data via the Eulerpool API
Get Free API Key

Remedent Stock analysis

What does Remedent do? Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remedent stock

Current Liabilities of Remedent is 2.88 M USD in 2024.

Current Liabilities of Remedent changed from 2.69 M USD to 2.88 M USD, representing a 7.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Remedent since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Remedent historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Remedent

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Remedent